Warning: Undefined array key "network" in /hshare1/ZETTAI_path_WA_slash_usr_slash_proj_KARA/usr/proj/tcng/htdocs/tcng.php on line 565
Edge
IL6 → PIM1
Networks Including this Edge
| GSE10780_egf1520 - GSE10780 - SiGN-BN HC+Bootstrap | Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue |
| GSE14764_egf1520 - GSE14764 - SiGN-BN HC+Bootstrap | A Prognostic Gene Expression Index in Ovarian Cancer |
| GSE15459_egf1520 - GSE15459 - SiGN-BN HC+Bootstrap | Gastric Cancer Project '08 (Singapore Patient Cohort) |
| GSE15852_egf1520 - GSE15852 - SiGN-BN HC+Bootstrap | Expression data from human breast tumors and their paired normal tissues |
| GSE16581_egf1520 - GSE16581 - SiGN-BN HC+Bootstrap | Genomic landscape of meningiomas: gene expression |
| GSE18497_egf1520 - GSE18497 - SiGN-BN HC+Bootstrap | Diagnosis-relapse in ALL |
| GSE19188_egf1520 - GSE19188 - SiGN-BN HC+Bootstrap | Expression data for early stage NSCLC |
| GSE19615_egf1520 - GSE19615 - SiGN-BN HC+Bootstrap | Integrated genomic and function characterization of the 8q22 gain |
| GSE19804_egf1520 - GSE19804 - SiGN-BN HC+Bootstrap | Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan |
| GSE21122_egf1520 - GSE21122 - SiGN-BN HC+Bootstrap | Whole-transcript expression data for soft-tissue sarcoma tumors and control normal fat specimens |
| GSE21653_egf1520 - GSE21653 - SiGN-BN HC+Bootstrap | A gene expression signature identifies two prognostic subgroups of basal breast cancer |
| GSE23772_egf1520 - GSE23772 - SiGN-BN HC+Bootstrap | Why does HAMLET preferentially kill tumor cells? p38-dependent death in tumor but up-regulation of innate immunity in healthy, differentiated cells |
| GSE26599_egf1520 - GSE26599 - SiGN-BN HC+Bootstrap | Gene expression profile in response to doxorubicin-rapamycin combined treatment of HER-2 overexpressing human mammary epithelial cell lines |
| GSE27155_egf1520 - GSE27155 - SiGN-BN HC+Bootstrap | Human thyroid adenomas, carcinomas, and normals |
| GSE30929_egf1520 - GSE30929 - SiGN-BN HC+Bootstrap | Whole-transcript expression data for liposarcoma |
| GSE31245_egf1520 - GSE31245 - SiGN-BN HC+Bootstrap | Unique gene expression profile based upon pathologic response in epithelial ovarian cancer |
| GSE3149_egf1520 - GSE3149 - SiGN-BN HC+Bootstrap | Ovarian Cancer Dataset |
| GSE31519_egf1520 - GSE31519 - SiGN-BN HC+Bootstrap | A Clinically Relevant Gene Signature in Triple-Negative and Basal-Like Breast Cancer |
| GSE4115_egf1520 - GSE4115 - SiGN-BN HC+Bootstrap | Airway Epithelial Gene Expression Diagnostic for the Evaluation of Smokers with Suspect Lung Cancer |
| GSE5327_egf1520 - GSE5327 - SiGN-BN HC+Bootstrap | Breast cancer relapse free survival and lung metastasis free survival |
| GSE5847_egf1520 - GSE5847 - SiGN-BN HC+Bootstrap | Tumor and stroma from breast by LCM |
| GSE6691_egf1520 - GSE6691 - SiGN-BN HC+Bootstrap | Gene expression profiling of B lymphocytes and plasma cells from WaldenstrÖm’s macroglobulinemia. |
| GSE6956_egf1520 - GSE6956 - SiGN-BN HC+Bootstrap | Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men |
| GSE8218_egf1520 - GSE8218 - SiGN-BN HC+Bootstrap | Gene expression data from prostate cancer samples |
| GSE8581_egf1520 - GSE8581 - SiGN-BN HC+Bootstrap | Human Chronic Obstructive Pulmonary Disorder (COPD) Biomarker |
